Lee Terence K, Poon Ronnie T P, Yuen Anthony P, Ling Ming Tat, Wang Xiang Hong, Wong Yong Chuan, Guan Xin Yuan, Man Kwan, Tang Zao You, Fan Sheung Tat
Department of Surgery, The University of Hong Kong, Hong Kong, China.
Clin Cancer Res. 2006 Dec 1;12(23):6910-9. doi: 10.1158/1078-0432.CCR-06-0489.
Metastasis is commonly associated with poor prognosis of hepatocellular carcinoma (HCC). Being an important angiogenic factor, vascular endothelial growth factor (VEGF) plays a central role in HCC growth and metastasis. Recently, Id-1 (inhibitor of differentiation/DNA synthesis) has been suggested to be a key factor in cancer progression but the molecular mechanism remains unknown.
We first showed that overexpression of Id-1 was correlated with HCC metastasis (P < 0.001) and its expression was significantly correlated with VEGF expression by tissue microarray. By ectopic transfection of Id-1 into HCC cells, Id-1 was able to induce VEGF secretion through activation of VEGF transcription.
Increased VEGF secretion in Id-1 transfectants induced morphologic change and proliferation of human umbilical vascular endothelial cell resulting in promotion of angiogenesis. Id-1 induced transcriptional activation of VEGF by stabilizing hypoxia-inducible factor-1alpha protein. Down-regulation of Id-1 by antisense approach led to suppression of hypoxia-inducible factor-1alpha-mediated VEGF production. In addition, Id-1 suppression resulted in retardation of cell invasion through down-regulation of VEGF.
Id-1 is a novel angiogenic factor for HCC metastasis and down-regulation of Id-1 may be a novel target to inhibit HCC metastasis through suppression of angiogenesis.
转移通常与肝细胞癌(HCC)的不良预后相关。血管内皮生长因子(VEGF)作为一种重要的血管生成因子,在HCC的生长和转移中起核心作用。最近,Id-1(分化/DNA合成抑制剂)被认为是癌症进展的关键因素,但其分子机制仍不清楚。
我们首先通过组织芯片显示Id-1的过表达与HCC转移相关(P < 0.001),并且其表达与VEGF表达显著相关。通过将Id-1异位转染到HCC细胞中,Id-1能够通过激活VEGF转录来诱导VEGF分泌。
Id-1转染细胞中VEGF分泌增加诱导了人脐静脉血管内皮细胞的形态变化和增殖,从而促进了血管生成。Id-1通过稳定缺氧诱导因子-1α蛋白诱导VEGF的转录激活。通过反义方法下调Id-1导致缺氧诱导因子-1α介导的VEGF产生受到抑制。此外,Id-1抑制导致通过下调VEGF而使细胞侵袭延迟。
Id-1是HCC转移的一种新型血管生成因子,下调Id-1可能是通过抑制血管生成来抑制HCC转移的新靶点。